Atlas market file · Equity · United States
Chime Financial, Inc.CHYM
- Last close
- 31.25
- Change
- +20.56%
- 96-bar range
- 15.88 – 33.41
- As of
- 6 Aug 2026
Chime Financial, Inc. is a finance services issuer listed as CHYM on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 62 weekly closes (-10.18% over the window).
Source rail: Yahoo Finance chart API (CHYM). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for CHYM. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
Atlas Pro artifact
CHYM Market Snapshot PDF
The latest snapshot audit passed. Atlas checks entitlement and evidence again when the PDF is requested.
Atlas Pro entitlement required. The release gate runs again when you request the file.
CHYM public profile
Finance services issuer. Chime Financial, Inc. is connected to current market context, cited company sources and its retained research file.
Chime Financial, Inc. trades as CHYM on NASDAQ. Chime Financial, Inc. (CHYM) has a latest verified close of 31.25, up 20.56%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files CHYM under USA Stocks and Financial Stocks for browsing.
What changed for Chime Financial, Inc. today
Chime Financial’s latest 10-Q paints a picture of a neobank in rude financial health: $647.4 million in revenue for the quarter ending 31 March 2026, $53.5 million of net income, and $607.7 million in cash and equivalents. The company’s press release celebrates “strong top-line momentum” with 25% year-over-year revenue growth and the first quarter of GAAP profitability since going public, while the filing quietly notes that $125.1 million of that revenue wasn’t derived from contracts with customers at all-it came from the bank partners who actually hold the deposits. It’s a neat trick, but one that depends on the kindness of strangers-or, more accurately, on the willingness of partner banks to keep lending their balance sheets to Chime’s marketing machine.
What Chime actually does is act as a front-end for FDIC-insured deposit products, debit cards, and secured credit cards, all delivered through its app and powered by contracts with unnamed bank partners. The company earns platform-related revenue from products like MyPay and Instant Loans, and it’s clear from the filing that the fastest-growing slice of that revenue comes from services that don’t require a customer to sign a contract with Chime itself. In other words, Chime’s growth story is built on partnerships, not on its own profitability per customer. The danger is that if those partners ever decide to renegotiate the economics-or, worse, if regulators take a dim view of the arrangement-the company’s headline numbers could evaporate faster than a fintech’s IPO pop.
Dig into the filings and the numbers tell a more nuanced story. The $647.4 million in revenue for the quarter includes $125.1 million of non-customer-derived platform revenue, which means the true customer-based revenue is closer to $522.3 million. Operating income clocks in at $46.2 million, which is healthy enough, but the company’s $109.8 million R&D spend-nearly 17% of revenue-suggests it’s still in full growth mode, not yet a cash-generating machine. Cash flow from operations is a respectable $87.5 million, but that’s after spending $5.7 million on property, plant, and equipment, a figure that would struggle to buy a single data centre in Silicon Valley. The company’s diluted EPS is $0.13 on 400.5 million shares, a dilution profile that would make even the most committed retail investor pause. The balance sheet may look flush, but the income statement and cash flow statement are whispering that Chime is still in the investment phase, not yet in harvest mode.
For context on the stock’s recent path, traders can track the ticker on the venue of their choice-no invented levels here, just the source-rail reminder that the market’s verdict is rendered in price, not in press releases. The raw facts are these: Chime is a neobank that relies on partner banks for its core product, its fastest-growing revenue streams are non-customer-derived, and its growth story is built on partnerships, not on its own unassailable economics. If the partner banks ever blink, the story blinks with them.
What remains unproven is whether Chime can convert its non-customer-derived revenue into customer-based, high-margin recurring income without triggering regulatory scrutiny or partner pushback. The company’s R&D intensity suggests it’s still chasing product depth, but depth doesn’t pay the bills until customers actually pay for it. The next earnings release-or, more importantly, the next contract renewal with a partner bank-will tell us whether Chime’s growth is sustainable or merely a balance-sheet illusion. Until then, the filings show a company that’s profitable on paper and growing fast, but whose true economics depend on the kindness of strangers and the patience of regulators. The tension sits between the polished platform story and the balance sheet reality: the cash is real, the growth is real, but the margin of safety is thin.
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
CHYM technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on CHYM
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep CHYM research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
CHYM FAQ
What is Chime Financial, Inc. (CHYM)?Chime Financial, Inc. (CHYM) has a latest verified close of 31.25, up 20.56%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed...
Chime Financial, Inc. (CHYM) has a latest verified close of 31.25, up 20.56%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for CHYM?Chime Financial, Inc. (CHYM) has a latest verified close of 31.25, up 20.56%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources,...
Chime Financial, Inc. (CHYM) has a latest verified close of 31.25, up 20.56%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files CHYM under USA Stocks and Financial Stocks for browsing.
How often is the CHYM page updated?The CHYM public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The CHYM public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for CHYM?The CHYM file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:CHYM. SEC EDGAR provides the filing anchor for this issuer. The page separates...
The CHYM file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:CHYM. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on CHYM?Yes. The workstation can open CHYM, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open CHYM, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this CHYM page investment advice?No. The CHYM page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The CHYM page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
CHYM
Equity · evidence first